-
Mashup Score: 9INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases | JCO Global Oncology - 6 hour(s) ago
PURPOSEThis manuscript reports the results of the Indian Network for Development of Peritoneal Surface Oncology and Indian Society of Peritoneal Surface Malignancies (INDEPSO-ISPSM) consensus that aimed to provide recommendations for some important …
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Emotional impact of cancer from a patient's perspective - 9 hour(s) ago
Your work in geriatric oncology places you in a unique position to help people in the most significant way possible–to literally save their lives. Such a duty of care is profound, perhaps even more so when you face the most vulnerable patients– including children, the underprivileged, or those diminished by prior illness or the aging process itself.
Source: www.geriatriconcology.netCategories: General Medicine News, Hem/OncsTweet-
RT @JGeriOnc: Emotional impact of cancer from a patient's perspective https://t.co/gEknMeCFMU @WilliamDale_MD @rochgerionc @myCARG #GeriOnc…
-
-
Mashup Score: 13The OncoAlert5k at SABCS24 - 1 day(s) ago
Warm invite to come for a healthy outing in front of the Alamo, we will take in the beauty of the riverwalk and get our steps in for this 5k(Walk/RUN)
Source: oncoalert.m-pages.comCategories: General Medicine News, Hem/OncsTweet-
RT @OncoAlert: The Oncoalert 5k Homecoming at #SABCS24 JOIN US!! Register here: https://t.co/0wlsCQBKNb Space is Limited Thursday Dec 12,…
-
-
Mashup Score: 11Genitourinary Cancer Expert Yüksel Ürün, MD, Shares His Career Journey and the Importance of Achieving a Work/Life Balance - 8 day(s) ago
In this installment of The ASCO Post’s Living a Full Life series, guest editor Jame Abraham, MD, FACP, spoke with medical oncologist Yüksel Ürün, MD, about his clinical and research career in oncology…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet-
RT @BbaharK: 👏🏻👏🏻How lucky we are to have you as our mentor and greatest supporter! @DrYukselUrun 🧿 https://t.co/o6DRKeVWgK https://t.co/fo…
-
-
Mashup Score: 11Genitourinary Cancer Expert Yüksel Ürün, MD, Shares His Career Journey and the Importance of Achieving a Work/Life Balance - 12 day(s) ago
In this installment of The ASCO Post’s Living a Full Life series, guest editor Jame Abraham, MD, FACP, spoke with medical oncologist Yüksel Ürün, MD, about his clinical and research career in oncology…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet-
RT @BbaharK: 👏🏻👏🏻How lucky we are to have you as our mentor and greatest supporter! @DrYukselUrun 🧿 https://t.co/o6DRKeVWgK https://t.co/fo…
-
-
Mashup Score: 11Genitourinary Cancer Expert Yüksel Ürün, MD, Shares His Career Journey and the Importance of Achieving a Work/Life Balance - 12 day(s) ago
In this installment of The ASCO Post’s Living a Full Life series, guest editor Jame Abraham, MD, FACP, spoke with medical oncologist Yüksel Ürün, MD, about his clinical and research career in oncology…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet-
RT @BbaharK: 👏🏻👏🏻How lucky we are to have you as our mentor and greatest supporter! @DrYukselUrun 🧿 https://t.co/o6DRKeVWgK https://t.co/fo…
-
-
Mashup Score: 11Genitourinary Cancer Expert Yüksel Ürün, MD, Shares His Career Journey and the Importance of Achieving a Work/Life Balance - 12 day(s) ago
In this installment of The ASCO Post’s Living a Full Life series, guest editor Jame Abraham, MD, FACP, spoke with medical oncologist Yüksel Ürün, MD, about his clinical and research career in oncology…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet-
RT @BbaharK: 👏🏻👏🏻How lucky we are to have you as our mentor and greatest supporter! @DrYukselUrun 🧿 https://t.co/o6DRKeVWgK https://t.co/fo…
-
-
Mashup Score: 5Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer | NEJM - 13 day(s) ago
In patients with early-stage triple-negative breast cancer, the phase 3 KEYNOTE-522 trial showed significant improvements in pathological complete response and event-free survival with the addition…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
RT @ElisaAgostinett: Simultaneous publication in @NEJM ⬇️ @OncoAlert https://t.co/jTkFPH3rUi
-
-
Mashup Score: 5Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer | NEJM - 14 day(s) ago
In patients with early-stage triple-negative breast cancer, the phase 3 KEYNOTE-522 trial showed significant improvements in pathological complete response and event-free survival with the addition…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
RT @ElisaAgostinett: Simultaneous publication in @NEJM ⬇️ @OncoAlert https://t.co/jTkFPH3rUi
-
-
Mashup Score: 5Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer | NEJM - 14 day(s) ago
In patients with early-stage triple-negative breast cancer, the phase 3 KEYNOTE-522 trial showed significant improvements in pathological complete response and event-free survival with the addition…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
RT @ElisaAgostinett: Simultaneous publication in @NEJM ⬇️ @OncoAlert https://t.co/jTkFPH3rUi
-
RT @Erman_Akkus: 📘Management of colorectal peritoneal metastases @JCOGO_ASCO 🟠Indian consensus statement 👉https://t.co/Oq1aG1qae4 @ASC…